Nim-NPs inhibit Wnt/β-catenin signaling by downregulating DNA methyltransferases, thus epigenetically restoring the expression of the secreted frizzled-related protein 1 (SFRP1) and resulting in tumor growth and metastasis formation inhibition without systemic toxicity. This evidence concerns the gene FRZB and neoplasm.